Beam stock forecast.

Beam Global : Expansion into ... The EV charging market is estimated to grow at a CAGR of 30% through the forecast period of 2021-2028 and reach $112 billion in ... The stock is up 24% in the past ...

Beam stock forecast. Things To Know About Beam stock forecast.

Tritium shares are priced at $6.34 and their average price target of $14.40 implies an upside potential of ~127%. ( See Tritium stock forecast on TipRanks) Beam Global, the second EV charging ...View the real-time BEAM price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees, ...Tritium shares are priced at $6.34 and their average price target of $14.40 implies an upside potential of ~127%. ( See Tritium stock forecast on TipRanks) Beam Global, the second EV charging ...The average Beam Therapeutics stock forecast 2024 represents a 80.7% increase from the last price of $28.5900001525879. For Beam Therapeutics stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Beam Therapeutics stock forecast of $75.12, a high forecast of $83.03, and a low forecast of $61.46.

Dec 1, 2023 · According to the issued ratings of 11 analysts in the last year, the consensus rating for Beam Therapeutics stock is Hold based on the current 6 hold ratings and 5 buy ratings for BEAM. The average twelve-month price prediction for Beam Therapeutics is $48.80 with a high price target of $105.00 and a low price target of $20.00. Learn more on ... According to the issued ratings of 3 analysts in the last year, the consensus rating for Beam Global stock is Moderate Buy based on the current 1 hold rating and 2 buy ratings for BEEM. The average twelve-month price prediction for Beam Global is $25.00 with a high price target of $25.00 and a low price target of $25.00.

$-4.18 Market Cap $2.02 B Shares Outstanding 81.50 M Public Float 68.49 M Yield BEAM is not currently paying a regular dividend. Latest Dividend N/A Ex-Dividend Date N/A Short Interest (10/31/23)...SGMO Stock 12 Months Forecast. $2.20. (514.01% Upside) Based on 7 Wall Street analysts offering 12 month price targets for Sangamo Biosciences in the last 3 months. The average price target is $2.20 with a high forecast of $3.00 and a low forecast of $1.00. The average price target represents a 514.01% change from the last price of $0.36.

Perform stock investment research with our IBD research tools to help investment strategies. We provide the resources to help make informed decisions.Find real-time DNA - Ginkgo Bioworks Holdings Inc stock quotes, company profile, ... EPS forecast (this quarter)-$0.07: Annual revenue (last year) $477.7M: Annual profit (last year)Following the upgrade, the consensus from 13 analysts covering Beam Therapeutics is for revenues of US$60m in 2023, implying a small 2.2% decline in sales compared to the last 12 months. Per-share ...Jul 15, 2023 · Here are two such stocks that could generate monstrous returns on capital over the long run. Image source: Getty Images. 1. Beam Therapeutics. Beam Therapeutics ( BEAM -1.72%) is a biotechnology ...

NTLA Stock 12 Months Forecast. Based on 19 Wall Street analysts offering 12 month price targets for Intellia Therapeutics in the last 3 months. The average price target is $78.65 with a high forecast of $136.00 and a low forecast of $31.00. The average price target represents a 151.68% change from the last price of $31.25.

Find real-time NCLH - Norwegian Cruise Line Holdings Ltd stock quotes, company profile, news and forecasts from CNN Business.

Oct 28, 2023 · Beam Therapeutics Inc. (BEAM) share price prediction for 2023, 2024, 2025, 2026 and 2027. BEAM one year forecast. Beam Therapeutics stock monthly and weekly forecasts. Apr 20, 2023 · Beam Therapeutics Inc Stock Price History. Beam Therapeutics Inc’s price is currently down 1.73% so far this month. During the month of April, Beam Therapeutics Inc’s stock price has reached a high of $32.82 and a low of $28.62. Over the last year, Beam Therapeutics Inc has hit prices as high as $73.27 and as low as $27.77. Year to date ... Aug 29, 2023 · These 4 analysts have an average price target of $48.5 versus the current price of Beam Therapeutics at $23.8, implying upside. Below is a summary of how these 4 analysts rated Beam Therapeutics ... $-4.18 Market Cap $2.02 B Shares Outstanding 81.50 M Public Float 68.49 M Yield BEAM is not currently paying a regular dividend. Latest Dividend N/A Ex-Dividend …Forecasted world HRC benchmark steel price for 2023. After demand for steel dropped during the arrival of the COVID-19 pandemic in 2019, steel prices also took a hit. However, in 2021, hot-rolled ...

That’s the promise investors like Cathie Wood see in BEAM stock. The science is not yet at that level, though, and Beam Therapeutics lost more than a quarter of a billion dollars in 2022.TTOO. T2 Biosystems, Inc. Common Stock. $0.56 +0.1067 +23.54%. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market ... BEAM stock, the ticker symbol for Beam Therapeutics Inc, experienced a significant increase in its price on October 19, 2023. According to data from CNN Money, 14 analysts have provided 12-month price forecasts for the stock. The median target price is $61.00, with a high estimate of $105.00 and a low estimate of $27.00.Dec 1, 2023 · Beam Therapeutics last released its earnings results on November 8th, 2023. The reported ($1.22) earnings per share for the quarter, beating analysts' consensus estimates of ($1.33) by $0.11. The firm had revenue of $17.20 million for the quarter, compared to analyst estimates of $17.09 million. Its revenue was up 8.9% on a year-over-year basis. Beam Therapeutics (BEAM) Stock Price, News & Analysis $29.47 +1.52 (+5.44%) (As of 05:07 PM ET) Compare Today's Range $28.28 $29.84 50-Day Range $17.69 $30.76 52-Week Range $16.95 $51.60 Volume 1.35 million shs Average Volume 986,767 shs Market Capitalization $2.40 billion P/E Ratio N/A Dividend Yield N/A Price Target $48.80

Predicting the weather has long been one of life’s great mysteries — at least for regular folks. Over the years, you’ve probably encountered a few older adults — maybe even your own grandparents — who made some weather predictions based on ...

Stock Forecast Based On a Predictive Algorithm | I Know First | Disclaimer: I Know First-Daily Market Forecast, does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any …Beam Therapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030. In the last three years, Beam Therapeutics's EPS has grown, increasing from $-2.49 to $-4.13 – an …It’s difficult to put a positive spin on the current state of the stock market. While 2022’s action has seen moments of relief, for the most part, the trend has been resolutely downbeat, as ...Beam Therapeutics, a leading biotechnology company specializing in the development of precision genetic medicines through base editing, has recently announced Beam Therapeutics Announces Strategic Restructuring and Portfolio Prioritization for Value Creation and LongTerm Growth - Best StocksWhen planning outdoor activities or making travel arrangements, having access to accurate weather forecasts is crucial. One commonly used tool is the 7 day weather forecast, which provides an outlook for the upcoming week.Next reporting date. February 13, 2024. EPS forecast (this quarter) -$0.20. Annual revenue (last year) $185.3M. Annual profit (last year) -$200.2M. Net profit margin.GLBE Stock 12 Months Forecast. $46.11. (31.33% Upside) Based on 9 Wall Street analysts offering 12 month price targets for Global-e Online in the last 3 months. The average price target is $46.11 with a high forecast of $50.00 and a low forecast of $41.00. The average price target represents a 31.33% change from the last price of $35.11.Hold candidate since Nov 13, 2023 Gain 20.46% PDF. The Beam Global stock price gained 20.46% on the last trading day (Tuesday, 14th Nov 2023), rising from $6.06 to $7.30. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days.

Nov 15, 2023 · Earnings vs Market: BEEM is forecast to become profitable over the next 3 years, which is considered above average market growth. High Growth Earnings: BEEM is expected to become profitable in the next 3 years. Revenue vs Market: BEEM's revenue (24.5% per year) is forecast to grow faster than the US market (7.7% per year).

Beam Global analyst ratings, historical stock prices, earnings estimates & actuals. BEEM updated stock price target summary.

Mar 15, 2021 · Based on those assumptions, my modeling says Aeva could do about $10 in earnings per share by 2030. A simple 20X multiple on that implies a long-term potential price target here of $200. The AEVA ... Aug 29, 2023 · These 4 analysts have an average price target of $48.5 versus the current price of Beam Therapeutics at $23.8, implying upside. Below is a summary of how these 4 analysts rated Beam Therapeutics ... BEAM : Suntory Holdings Completes Acquisition of Beam Inc. 2014: BU BEAM : Jim Beam To Host "Distillery Days" In Clermont 2014: PR Beam : Announces Intention to Delist and Deregister Common Stock, 8 5/8% Debentures Due 2021 and 7 …As for the stock performance of Beam Therapeutics, on October 2nd, it opened at $24.05. Over the past 50 days, the stock has exhibited a moving average price of $25.47, while its 200-day moving average stands at $29.78. It is worth noting that BEAM’s fifty-two week low is reported to be $22.52, with a high point of $54.30 during the same period.The Beam Therapeutics stock forecast is 57.069107374265 USD for 2024 November 25, Monday; and 177.367 USD for 2028 November 25, Saturday with technical analysis. Beam Therapeutics (BEAM) stock price prediction is 57.069107374265 USD.Ouster (NYSE: OUST) While its ticker symbol sounds ominous, Ouster LiDAR stocks could have a bright future ahead, especially within the next few years. This San Francisco-based company produces …Find real-time UBER - Uber Technologies Inc stock quotes, company profile, news and forecasts from CNN Business.According to the issued ratings of 3 analysts in the last year, the consensus rating for Beam Global stock is Moderate Buy based on the current 1 hold rating and 2 buy ratings for BEEM. The average twelve-month price prediction for Beam Global is $25.00 with a high price target of $25.00 and a low price target of $25.00.Ouster (NYSE: OUST) While its ticker symbol sounds ominous, Ouster LiDAR stocks could have a bright future ahead, especially within the next few years. This San Francisco-based company produces …

Jun 12, 2022 · Beam Therapeutics Let’s start off in the high-risk, high-reward biotech sector. ... (See IHRT stock forecast on TipRanks) To find good ideas for stocks trading at attractive valuations, visit ... Average 51.83 75.87% Upside Low 19.00 -35.53% Downside High 95.00 222.36% Upside Broker Rating Beam Therapeutics Inc. currently has an average brokerage recommendation (ABR) of 1.86 on a scale of... Weather forecasting plays a crucial role in our daily lives, helping us plan our activities and make informed decisions. But have you ever wondered how meteorologists are able to accurately predict the weather? One of the key components in ...The global welding market size was valued at USD 23.75 billion in 2022. The market is projected to grow from USD 24.73 billion in 2023 to USD 34.18 billion by 2030, exhibiting a CAGR of 4.7% during the forecast period. The welding industry has witnessed significant technological advancements in recent years, including the development of new ...Instagram:https://instagram. nyseamerican uuuubest retirement planner appapple stock optionschaikin stock pick Weather forecasts are essential tools for planning our daily activities, especially when it comes to the next 10 days. Understanding a weather 10 day forecast can help us make informed decisions about outdoor events, travel plans, or even w... audrain concourstoyota flying car price Aug 13, 2023 · The Vanguard Group, Inc. is the second largest shareholder owning 8.3% of common stock, and Arch Venture Partners, L.P. holds about 7.1% of the company stock. Furthermore, CEO John Evans is the ... fake stocks screen GLBE Stock 12 Months Forecast. $46.11. (31.33% Upside) Based on 9 Wall Street analysts offering 12 month price targets for Global-e Online in the last 3 months. The average price target is $46.11 with a high forecast of $50.00 and a low forecast of $41.00. The average price target represents a 31.33% change from the last price of $35.11.Stock Price Forecast The 12 analysts offering 12-month price forecasts for Beam Therapeutics Inc have a median target of 46.50, with a high estimate of 95.00 and a low estimate of 19.00. The median estimate represents a +57.09% increase from the last price of 29.60.It’s difficult to put a positive spin on the current state of the stock market. While 2022’s action has seen moments of relief, for the most part, the trend has been resolutely downbeat, as reflected in the main indexes’ performances. All are down by at least double-digits; the tech-heavy NASDAQ’s 27% drop has been the most acute, while the …